As per the partnership, France-based Sanofi will contribute its S-protein COVID-19 antigen, which is based on recombinant DNA technology. London-headquartered GSK, on the other hand, will contribute its proven pandemic adjuvant technology.
Mumbai: As India deals with increasing number of dengue cases, pharma major Sanofi on Tuesday said the world's first vaccine against the mosquito-borne viral disease may be available by the second half of 2015.Sanofi Pasteur,
Mumbai: Glenmark Pharmaceuticals Ltd has been sued by Sanofi, SA, in a US court after the Indian company filed an application with the US Food and Drug Administration (FDA). According to FDA, the company seeks
Top News
Latest News
